lobbying_activities: 1812459
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1812459 | e5ffe25e-d235-4283-844d-bbce90b502a4 | Q1 | GILEAD SCIENCES, INC. | 287177 | GILEAD SCIENCES INC | 2016 | first_quarter | VET | Appropriations; education related to Hepatitis C treatment guidelines and funding issues. Issues related to coverage, access and reimbursement of pharmaceuticals for veterans. Education related to Implementation of Veterans Access to Care Act, HR 4810/3230 and PL 113-146. | Commerce, Dept of (DOC),Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),Veterans Affairs, Dept of (VA) | 980000 | 0 | 0 | 2016-04-18T18:12:02-04:00 |